Showing 1 to 1 of 1 results
euronews.com
🌐 85% Global Worthiness


Pfizer to Acquire Metsera for $4.9 Billion to Enter Obesity Drug Market
Pfizer announced a $4.9 billion cash acquisition of Metsera, a biopharmaceutical firm with a pipeline of obesity and cardiometabolic disease treatments, to expand into the growing obesity drug market.
Pfizer to Acquire Metsera for $4.9 Billion to Enter Obesity Drug Market
Pfizer announced a $4.9 billion cash acquisition of Metsera, a biopharmaceutical firm with a pipeline of obesity and cardiometabolic disease treatments, to expand into the growing obesity drug market.
Progress
44% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results